RTA 408
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for RTA 408, covering 2020-09-17 to 2025-05-29. Get the full timeline:
Most recent: Clinical Trial Update: RTA 408 in the Treatment of Advanced Solid Tumors (NSCLC & Melanoma) - DISCOVER [Phase 1]